Eisai, Biogen to advance Alzheimer's drug, provide fresh hope Ruby Khatun Khatun25 July 2018 9:45 AM ISTEisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working with...
GSK's two-drug HIV treatment proves itself in key tests Ruby Khatun Khatun25 July 2018 9:30 AM ISTLONDON: GlaxoSmithKline's (GSK) simple two-drug treatment for HIVworks as well as standard triple therapy, even in people with relatively high levels...
Analjit Singh appointed chairman of Max Financial Services Ruby Khatun Khatun24 July 2018 10:15 AM ISTNew Delhi: At its meeting earlier Monday, the Board of Max Financial Services (MFS), holding company of life insurance business of $3 billion Max...
USFDA staff raises efficacy doubts on GSK's lung disease treatment Ruby Khatun Khatun24 July 2018 10:00 AM ISTU.S. Food and Drug Administration staff reviewers have raised doubts over the effectiveness of GlaxoSmithKline Plc’s (GSK) drug Nucala in treating a...
China vaccine scandal ripples through domestic market, threatens global push Ruby Khatun Khatun24 July 2018 9:45 AM ISTSHANGHAI: A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples...
AstraZeneca to stockpile drugs as Brexit safety net Ruby Khatun Khatun24 July 2018 9:30 AM ISTLONDON: AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in...
Dr Reddy's launches OTC acid reflux drug in US market Ruby Khatun Khatun23 July 2018 10:30 AM ISTNew Delhi: Drug major Dr Reddy's Laboratories (DRL) announced the launch of over-the-counter Esomeprazole magnesium delayed-release capsules USP, 20...
FDA approves targeted AML therapy Ruby Khatun Khatun23 July 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory...
Buyout firm Apollo in advanced talks to buy LifePoint Health - sources Ruby Khatun Khatun23 July 2018 10:00 AM ISTNew Delhi: Private equity firm Apollo Global Management LLC is in advanced talks to acquire LifePoint Health Inc, in its latest bid to consolidate the...
Swiss, German drugmakers join US price freeze Ruby Khatun Khatun23 July 2018 9:45 AM ISTZURICH: European drugmakers Roche, Bayer and Merck KGaA became the latest companies to freeze prices in the United States for the rest of 2018...
Bayer to phase out Essure birth control device in US Ruby Khatun Khatun23 July 2018 9:30 AM ISTNEW YORK: Life sciences company Bayer AG said it would discontinue the sale of its birth control product Essure in the United States, citing a decline...
Zydus Cadila gets USFDA approval for high blood pressure, heart failure treatment drug Ruby Khatun Khatun22 July 2018 10:45 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Spironolactone tablets, used to treat high blood pressure...
